Article
Berberine inhibits non‐small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis
27 Aug 2021
Abstract excerpt
At present, there are still many problems in the treatment of lung cancer, such as high cost, side effects and low quality of life. The advantages of traditional Chinese medicine (TCM) in the treatment of lung cancer are reflected. Berberine has been increasingly popular in colorectal cancer treatment, but little is known about its bioactivity against non-small cell lung cancer (NSCLC). Cell proliferation, cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
